 EMERYVILLE, Calif. , Oct. 14, 2022 PRNewswire -- Dynavax Technologies Corporation Nasdaq: DVAX, a commercial-stage biopharmaceutical company developing and commercializing innovative vaccines, today announced that Ryan Spencer , Chief Executive Officer, will present at the H.C. 